Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

allergan

Teva to switch generics focus to Allergan

July 27, 2015 Sales and Marketing Allergan, Teva, generics, mergers and acquisitions, pharma mergers and acquisitions

Teva is in negotiations to buy Allergan’s generics division for upwards of $40 billion, according to reports. The generics firm …
News
Novartis image

FDA approves Novartis drug Odomzo

July 27, 2015 Sales and Marketing Novartis, Odomzo, basal cell carcinoma, skin cancer

The FDA has given the Swiss firm the go-ahead to market its drug for skin cancer. Odomzo (sonidegib, formerly LDE225) …
News
Vaccination

EMA backs GSK’s malaria vaccine for use in Africa

July 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, Committee for Medicinal Products for Human USE, EMA, European Medicines Agency, GSK, WHO, malaria, world health organization

GSK has taken a significant step forward toward being the first company to bring a malaria vaccine to market, after …
News
Keytruda image

European Commission approves Merck’s Keytruda for melanoma drug

July 23, 2015 Sales and Marketing

The European Commission has approved Merck’s Keytruda (pembrolizumab) as a skin cancer treatment. Keytruda, the company’s successful anti-PD-L1 therapy and …
News
MabThera

Cancer and immunology drugs drive strong Roche sales performance

July 23, 2015 Sales and Marketing Roche, Severin Schwan, financials

Sales at Roche rose 6% in the first half of 2015, buoyed by “significant growth of sales and immunology medicines”, …
News
rtorbett

New ABPI executive director appointed

July 21, 2015 Manufacturing and Production, Research and Development, Sales and Marketing ABPI, Richard Corbett

The UK pharma trade body the ABPI has appointed Richard Corbett as its new executive director of commercial. Corbett will …
Appointment

Amgen’s Repatha wins PCSK9 heart drug race

July 21, 2015 Sales and Marketing Amgen, European Commission, PCKS9, Repatha, evolocumab, high cholesterol

The European Commission has signed off on Amgen’s Repatha, making it the first in a new class of cholesterol-lowering drugs …
News
Novartis

Sandoz and pharma division boost Novartis sales

July 21, 2015 Sales and Marketing Alcon, Novartis, Sandoz, financial performance, financial results, income, profits, sales

Sales at Novartis reached $12.7 billion in the second quarter of 2015, while its operating income was $2.3 billion, the …
News
Egyptian flag

Valeant in $800 million deal for Amoun Pharma

July 20, 2015 Sales and Marketing Amoun, Egypt, MENA, Valeant, acquisitions

Valeant is striking out in the acquisitions market yet again, having agreed an $800 million deal to buy Egypt’s largest …
News
Janssen image

European Imbruvica approval for Janssen

July 20, 2015 Medical Communications, Sales and Marketing B-cell lymphoma, EC, European Commission, Janssen, Waldenström’s Macroglobulinemia, imbruvica, rare cancer

Janssen has received final European sign-off for its oncology treatment Imbruvica (ibrutinib) as a treatment option for adult patients with …
News
Chugai

Chugai falls foul of ABPI code for close consultant relationship

July 17, 2015 Medical Communications, Sales and Marketing ABPI Code, Chugai, PMCPA, Prescription Medicines Code of Practice Authority

Bosses at Chugai have been rapped by the industry’s code of practice regulator, after a senior manager failed to declare …
News
AstraZeneca

AstraZeneca receives US approval for Iressa

July 16, 2015 Medical Communications, Sales and Marketing AstraZeneca, FDA, Iressa, lung cancer, non-small cell lung cancer

AstraZeneca’s lung cancer therapy Iressa has been approved by the FDA – four years after the company pulled it from the …
News
ABPI

UK pharma made £41 million in doctor payments

July 16, 2015 Medical Communications, Sales and Marketing ABPI, ABPI Code, doctor payments

The pharma industry made £41m in payments to doctors, nurses and other healthcare professionals in the UK in 2014, the …
News
brandicourt

New Sanofi boss Brandicourt restructures global business

July 16, 2015 Sales and Marketing Oliver Brandicourt, Sanofi

Sanofi is reorganising its pharmaceuticals division to create three new business units from January 2016. Chief executive Oliver Brandicourt has …
News

Janssen sales follow J&J’s downward trend

July 15, 2015 Sales and Marketing J&J, JJ, Johnson & Johnson, Johnson and Johnson, financial results, olysio

Strong sales of its new hepatitis C treatment Olysio were not enough to stop a slump in profits at J&J’s …
News
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026